This application is for renewal of a grant for funds to support 5 pre-doctoral and 4 post-doctoral trainees in the Immunology Training Program in Denver. Training is performed at three institutions, at the University of Colorado at Denver (UCD) and its associated Barbara Davis Center for Childhood Diabetes, and at National Jewish Health (NJH). All the faculty on this application are primary or secondary members of the Integrated Department of Immunology which, as its name suggests, is shared between UCD and NJH. The interests of the 28 faculty on this application represent modern immunological research ranging from lymphocyte and myeloid cell development and function to studies on infectious disease and autoimmunity in humans. Indeed, in response to changes in the nature of immunological research and the desires of incoming trainees, several physician scientists have been added to the list of trainers in this renewal application. This grant is headed by Dr. Philippa Marrack, a well known expert in T cell biology who has a long career in training pre- and post-doctoral fellows. She will be helped by Dr. Raul Torres, the Director of the Ph.D. training Program in the Immunology Department and a Steering Committee. Trainees will be chosen from pre- and post-doctoral fellows in the laboratories of any of the faculty on the program. Predoctoral fellows will be appointed after their first year in the program, when they have chosen and begun work in their training laboratories. Both pre- and post-doctoral trainees will be selected, by the Steering Committee, for appointment to the grant based on the merit of their work and their record. Trainees will be required to take a formal course in the Ethics and Conduct of Science and to attend and present in weekly """"""""Research in Progress"""""""" sessions. Attendance at journal clubs, weekly seminars given by invited speakers from around the world and scientific symposia will be encouraged. Trainee advisory committees will meet with the trainees at least twice per year to provide guidance on research and career direction. This program has a long and distinguished record, with almost all its predoctoral trainees continuing to excellent postdoctoral work and most of its pre- and post-doctoral trainees continuing, once they finish their postdoctoral work, with careers in science. The program has seen increasing recruiting of underrepresented minorities trainees over the years and has been, and continues to be, a major focus for immunological research in the Rocky Mountain region in particular and the USA in general.

Public Health Relevance

Immunity is crucial to human and animal health. Its contribution can be increased with the use of vaccines to prevent infection and treat cancer and immunosuppressants to reduce autoimmunity. Trainees supported by this grant will become the future scientists who will work towards increased understanding of the immune system and better ways to treat human patients.)

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007405-23
Application #
8501225
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
1991-09-30
Project End
2016-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
23
Fiscal Year
2013
Total Cost
$385,155
Indirect Cost
$28,012
Name
University of Colorado Denver
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Tuttle, Kathryn D; Krovi, S Harsha; Zhang, Jingjing et al. (2018) TCR signal strength controls thymic differentiation of iNKT cell subsets. Nat Commun 9:2650
Thompson, Scott B; Wigton, Eric J; Krovi, Sai Harsha et al. (2018) The Formin mDia1 Regulates Acute Lymphoblastic Leukemia Engraftment, Migration, and Progression in vivo. Front Oncol 8:389
Lucas, Erin D; Finlon, Jeffrey M; Burchill, Matthew A et al. (2018) Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response. J Immunol 201:1735-1747
Liu, Haolin; Wang, Chao; Lee, Schuyler et al. (2018) Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7. Sci Rep 8:3275
Schroeder, Kristin Ms; Agazio, Amanda; Torres, Raul M (2017) Immunological tolerance as a barrier to protective HIV humoral immunity. Curr Opin Immunol 47:26-34
Dillon, Stephanie M; Castleman, Moriah J; Frank, Daniel N et al. (2017) Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation. J Acquir Immune Defic Syndr 76:431-437
Barrett, Bradley S; Harper, Michael S; Jones, Sean T et al. (2017) Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction. Retrovirology 14:25
Lee, Schuyler; Wang, Chao; Liu, Haolin et al. (2017) Hydrogen bonds are a primary driving force for de novo protein folding. Acta Crystallogr D Struct Biol 73:955-969
Coleman, Carrie B; Daud, Ibrahim I; Ogolla, Sidney O et al. (2017) Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children. J Infect Dis 216:670-677
Schroeder, Kristin M S; Agazio, Amanda; Strauch, Pamela J et al. (2017) Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies. J Exp Med 214:2283-2302

Showing the most recent 10 out of 114 publications